These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 983738)

  • 1. Sodium excretion and sodium-free volume expansion in dogs: effect of inhibition of aldosterone activity by canrenoate.
    Bie P
    Acta Physiol Scand; 1976 Oct; 98(2):272-4. PubMed ID: 983738
    [No Abstract]   [Full Text] [Related]  

  • 2. Spirolactones: clinical and pharmacologic studies.
    Corvol P; Claire M; Rafestin-Oblin ME; Michaud A; Roth-Meyer C; Menard J
    Adv Nephrol Necker Hosp; 1977; 7():199-215. PubMed ID: 208407
    [No Abstract]   [Full Text] [Related]  

  • 3. Re-evaluation of the antimineralocorticoid effect of the spironolactone metabolite, canrenone, from plasma concentrations determined by a new high-pressure liquid-chromatographic method.
    Dahlöf CG; Lundborg P; Persson BA; Regårdh CG
    Drug Metab Dispos; 1979; 7(2):103-7. PubMed ID: 38071
    [No Abstract]   [Full Text] [Related]  

  • 4. Natriuresis in conscious dogs caused by increased carotid [Na+] during angiotensin II and aldosterone blockade.
    Emmeluth C; Drummer C; Gerzer R; Bie P
    Acta Physiol Scand; 1994 Jul; 151(3):403-11. PubMed ID: 7976412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potassium prorenoate: a new steroidal aldosterone antagonist.
    Hofmann LM; Chinn LJ; Pedrera HA; Krupnick MI; Suleymanov OD
    J Pharmacol Exp Ther; 1975 Aug; 194(2):450-6. PubMed ID: 1151770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interference of canrenoate potassium with plasma renin activity. Note I. Effects of canrenoate potassiumon plasma renin activity in patients with essential hypertension].
    Consolo F; Ferraù O; Pitrone F; Luzza G; Russo A; Virga T
    Boll Soc Ital Biol Sper; 1975 Dec; 51(24):1943-9. PubMed ID: 1231877
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in lymphocytes caused by aldosterone and a spironolactone derivative. Animal experiments and clinical studies].
    Liebich HG; Mertin J; Seifert J
    Fortschr Med; 1982 Nov; 100(41):1922-5. PubMed ID: 7152425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective stimulation of renal PGE2 by potassium canrenoate in essential hypertension.
    Castellani S; Scarti L; Masotti G; Del Rosso A; Chen JI; Neri Serneri GG
    Prog Clin Biol Res; 1989; 301():297-301. PubMed ID: 2678128
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of aldosterone antagonist canrenone on plasma aldosterone concentration and plasma renin activity, and on the excretion of aldosterone and electrolytes by man.
    Erbler HC; Wernze H; Hilfenhaus M
    Eur J Clin Pharmacol; 1976 Feb; 9(4):253-7. PubMed ID: 971711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in aldosterone and PRA due to the administration of potassium canrenoate in laparotomized patients with liver cirrhosis].
    Ikebe H; Hoashi S; Irie F; Taniguchi K; Honda N; Mitarai Y; Kobayashi N
    Masui; 1988 May; 37(5):546-51. PubMed ID: 3045361
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of potassium canrenoate on arterial pressure, plasma renin activity and urinary aldosterone in essential hypertension].
    Opocher G; Armanini D; Fallo F; Mantero F
    Boll Soc Ital Cardiol; 1978; 23(10):1757-66. PubMed ID: 400390
    [No Abstract]   [Full Text] [Related]  

  • 12. Antioestrogenic action of the aldosterone antagonist canrenoate K in the rat (adenohypophysis, ceruloplasmin).
    Schreiber V; Pribyl T
    Physiol Bohemoslov; 1977; 26(5):385-95. PubMed ID: 144921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of aldosterone production in diuretic-induced hyperaldosteronism by aldosterone antagonist canrenone in man.
    Erbler HC
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 285(4):395-401. PubMed ID: 4280522
    [No Abstract]   [Full Text] [Related]  

  • 14. Bradykinin (BK) enhances diuresis and natriuresis in saline volume-expanded dogs.
    Honda K; Nunokawa A; Nagasaka M
    Adv Exp Med Biol; 1989; 247A():287-91. PubMed ID: 2690589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive inotropic effect of K-canrenoate: an investigation in anaesthetized dogs, untreated or treated with digitalis.
    Marchetti G; Vitolo E; Di Francesco GF; Cavallaro B; Sponzilli C
    Arch Int Pharmacodyn Ther; 1983 Dec; 266(2):250-63. PubMed ID: 6667069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oryeongsan (Wulingsan), a traditional Chinese herbal medicine, induces natriuresis and diuresis along with an inhibition of the renin-angiotensin-aldosterone system in rats.
    Ahn YM; Cho KW; Kang DG; Lee HS
    J Ethnopharmacol; 2012 Jun; 141(3):780-5. PubMed ID: 22366680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of chlorthiazide treatment on renin-aldosterone system during pregnancy.
    Lammintausta R; Erkkola R; Eronen M
    Acta Obstet Gynecol Scand; 1978; 57(5):389-92. PubMed ID: 726871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proceedings: Acute and chronic effects of the aldosterone antagonist spironolactone and its main metabolite canrenone on plasma aldosterone concentration, plasma renin activity, serum electrolytes and on the excretion of aldosterone, fluid and electrolytes in rats.
    Erbler HC; Hilfenhaus M
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 287 Suppl():R52. PubMed ID: 1143449
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of canrenoate K on corticosteroid biosynthesis in nephrectomized dogs.
    Lasaridis AN; Tourkantonis A; Spanos P; Apostolopoulou K; Pharmakiotis A
    J Steroid Biochem; 1984 Apr; 20(4A):923-9. PubMed ID: 6323885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma digoxin radioimmunoassay in patients treated with potassium canrenoate and spironolactone. A comparison of two commerical kits.
    Cristodorescu R; Gavrilescu S; Deutsch G; Berger E
    Agressologie; 1978; 19(6):409-14. PubMed ID: 751526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.